Autres langues SCL Science Inc.

Actions

A246960

KR7246960009

Produits pharmaceutiques

Cours en clôture Korea S.E. 23/09/2026			Varia. 5j.	Varia. 1 janv.
2 720,00 ^KRW	+11,25%		+20,09%	+18,26%

14/08	SCL Science Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
15/05	SCL Science Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Autres langues

14/08	SCL Science Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
15/05	SCL Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
23/03	SCL Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
23/12	SCL Science Inc. agreed to acquire Bio-logistics business in Honam region of Seoul Clinical Laboratories for KRW 4.3 billion.
14/11	SCL Science Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
11/09/25	Scl Science to acquire 1.6 billion won worth of shares and majority stake in Pentamedix Co Ltd
11/09/25	SCL Science Inc. agreed to acquire 60.31% stake in PentaMedix Co., Ltd. for KRW 1.6 billion.
14/08/25	Scl Science wins 530 million won order
14/08/25	SCL Science Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
28/07/25	SCL Science Inc. agreed to acquire Bio-logistics business in Yeongnam region of Seoul Clinical Laboratories from Seoul Clinical Laboratories for KRW 5.0 billion.
15/05/25	SCL Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025
31/03/25	SCL Science Inc. completed the acquisition of SCL Healthcare Co., Ltd.
20/03/25	SCL Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2024
03/01/25	SCL Science Inc. announced that it has received KRW 14 billion in funding from a group of investors
30/12/24	SCL Science Inc. agreed to acquire SCL Healthcare Co., Ltd. for approximately KRW 10 billion.
30/12/24	SCL Science Inc. announced that it expects to receive KRW 14 billion in funding from a group of investors
14/11/24	SCL Science Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
07/02/24	H2U Corp. announced that it has received KRW 1.29506497 billion in funding from InnoTherapy, Inc.
30/11/23	H2U Corp. announced that it has received KRW 1.2171 billion in funding from InnoTherapy, Inc.
17/11/23	InnoTherapy, Inc. announced that it has received KRW 5.9999961 billion in funding from Scl Holdings and another investor
09/11/23	Health to U Corporation announced that it has received funding from InnoTherapy, Inc.
08/11/23	H2U Corp. announced that it expects to receive KRW 1.2171 billion in funding from InnoTherapy, Inc.
25/10/23	InnoTherapy, Inc. announced that it expects to receive KRW 5.9999961 billion in funding
07/07/23	PhAST Corp. announced that it has received KRW 1.30609774 billion in funding from InnoTherapy, Inc.
30/06/23	Lee Moon Su completed the acquisition of a 98.04% stake in NVC 2019 Bio Health Care Investment Association from InnoTherapy, Inc.